Bispecific synthetic antibodies are generated through a site-selective disulfide rebridging reaction followed by a bioorthogonal chemical ligation.
CITATION STYLE
Wang, R., & Zou, P. (2023). Bioorthogonal Chemical Ligation Creates Synthetic Antibodies with Improved Therapeutic Potency. ACS Central Science, 9(3), 349–351. https://doi.org/10.1021/acscentsci.3c00240
Mendeley helps you to discover research relevant for your work.